This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Tech Rumor of the Day: Apple

Apple (AAPL - Get Report) named its keynote speaker for the June 8 World Wide Developers' Conference and, it's not Steve Jobs.

Apple says Mac showman and marketing chief Phil Schiller will lead a team of executives in a presentation of the iPhone 3.0 software and its so-called Snow Leopard Mac operating system.

Now that Jobs is officially not the key speaker, Apple watchers are speculating that he could at least make an appearance.

This is among the bigger events on Apple's calendar. Among other things, analysts expect Apple to unveil the latest version of the iPhone, which as we reported, may include a cheaper calling plan from AT&T (T).

It was in June last year, during the 3G iPhone introduction, that Jobs appeared alarmingly thin setting off speculation about his health. Jobs got treatment for pancreatic cancer in 2004.

In January, Apple announced that Jobs would not attend its annual MacWorld show. The scratch started another round of chatter about Jobs' health.

After nothing but silence in the face of mounting concerns about his health, the Apple co-founder and CEO issued a statement blaming a "hormone imbalance" for his weight loss.

Nine days later, Apple announced that Steve Jobs would take a medical leave until the end of June and that COO Tim Cook would serve as interim chief.

An early showing by Jobs at the June 8 conference would make for a triumphant return, but don't get your hopes up.

Jobs was too weak to attend a town council meeting April 28 in Woodside, Calif., to argue that he should be allowed to tear down his 14-bedroom house and build a new one, according to a report by the Pallo Alto Daily News.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,434.19 -244.51 -1.38%
S&P 500 2,035.32 -21.77 -1.06%
NASDAQ 4,705.3560 -66.4070 -1.39%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs